A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
ConditionDry Eye Disease (DED)
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorOculis
About this trial
The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
Eligibility criteria
Qualifiers
Physician diagnosis of Dry Eye Disease in the past 6 months
Use of over-the-counter tears
Must agree to genotype testing
Disqualifiers
None
Trial design
Treatments tested in this trial
- Artificial Tear Run-in
- licaminlimab
- Vehicle of licaminlimab
Treatment groups
160 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov